Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126961931 | 12696193 | 1 | I | 20160822 | 20160829 | 20160829 | EXP | GB-TEVA-685387ACC | GB-FRI-1000087129 | FOREST | 0.00 | A | F | Y | 0.00000 | 20160829 | OT | DK | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126961931 | 12696193 | 1 | PS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | 30 MG DAILY | U | 20822 | |||||||||
| 126961931 | 12696193 | 2 | SS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | 12 MG DAILY | U | 20822 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126961931 | 12696193 | 1 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126961931 | 12696193 | DS |
| 126961931 | 12696193 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126961931 | 12696193 | Abdominal pain upper | |
| 126961931 | 12696193 | Chills | |
| 126961931 | 12696193 | Constipation | |
| 126961931 | 12696193 | Critical illness | |
| 126961931 | 12696193 | Diarrhoea | |
| 126961931 | 12696193 | Hyperhidrosis | |
| 126961931 | 12696193 | Nausea | |
| 126961931 | 12696193 | Vomiting | |
| 126961931 | 12696193 | Withdrawal syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |